AI assistant
Sending…
Clene Inc. — Director's Dealing 2022
Feb 3, 2022
34487_dirs_2022-02-03_5be5d435-6d17-4383-a69a-fb89e1c5c2e5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Clene Inc. (CLNN)
CIK: 0001822791
Period of Report: 2022-02-01
Reporting Person: BROWN MORGAN R (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-02-01 | Stock Options (Right to buy) | $2.96 | A | 250000.00 | Acquired | 2032-02-01 | Common Stock (250000.00) | Direct |
Footnotes
F1: This option was granted on February 1, 2022 as an option for 250,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $2.96 per share. The options vest with respect to the first 25% of such shares on February 1, 2023 and then in 36 equal installments of the balance of the shares of Common Stock on the last day of each calendar month, beginning February 1, 2023, until such shares are fully vested
More from Clene Inc.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 4
Annual Report
2026
Mar 17
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 20